• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

II型致死性发育不全侏儒症中突变型成纤维细胞生长因子受体对Stat1的激活作用。

Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism.

作者信息

Su W C, Kitagawa M, Xue N, Xie B, Garofalo S, Cho J, Deng C, Horton W A, Fu X Y

机构信息

Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520-8023, USA.

出版信息

Nature. 1997 Mar 20;386(6622):288-92. doi: 10.1038/386288a0.

DOI:10.1038/386288a0
PMID:9069288
Abstract

The achondroplasia class of chondrodysplasias comprises the most common genetic forms of dwarfism in humans and includes achondroplasia, hypochondroplasia and thanatophoric dysplasia types I and II (TDI and TDII), which are caused by different mutations in a fibroblast growth-factor receptor FGFR3 (ref. 1). The molecular mechanism and the mediators of these FGFR3-related growth abnormalities are not known. Here we show that mutant TDII FGFR3 has a constitutive tyrosine kinase activity which can specifically activate the transcription factor Stat1 (for signal transducer and activator of transcription). Furthermore, expression of TDII FGFR3 induced nuclear translocation of Stat1, expression of the cell-cycle inhibitor p21(WAF1/CIP1), and growth arrest of the cell. Thus, TDII FGFR3 may use Stat1 as a mediator of growth retardation in bone development. Consistent with this, Stat1 activation and increased p21(WAF1/CIP1) expression was found in the cartilage cells from the TDII fetus, but not in those from the normal fetus. Thus, abnormal STAT activation and p21(WAF1/CIP1) expression by the TDII mutant receptor may be responsible for this FGFR3-related bone disease.

摘要

软骨发育不全类的软骨发育异常包括人类最常见的侏儒症遗传形式,其中有软骨发育不全、低软骨发育不全以及致死性骨发育不全I型和II型(TDI和TDII),这些是由成纤维细胞生长因子受体FGFR3中的不同突变引起的(参考文献1)。这些与FGFR3相关的生长异常的分子机制和介质尚不清楚。在此我们表明,突变型TDII FGFR3具有组成型酪氨酸激酶活性,可特异性激活转录因子Stat1(信号转导和转录激活因子)。此外,TDII FGFR3的表达诱导了Stat1的核转位、细胞周期抑制剂p21(WAF1/CIP1)的表达以及细胞生长停滞。因此,TDII FGFR3可能利用Stat1作为骨发育中生长迟缓的介质。与此一致的是,在TDII胎儿的软骨细胞中发现了Stat1激活和p21(WAF1/CIP1)表达增加,而在正常胎儿的软骨细胞中未发现。因此,TDII突变受体引起的异常STAT激活和p21(WAF1/CIP1)表达可能是这种与FGFR3相关的骨病的原因。

相似文献

1
Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism.II型致死性发育不全侏儒症中突变型成纤维细胞生长因子受体对Stat1的激活作用。
Nature. 1997 Mar 20;386(6622):288-92. doi: 10.1038/386288a0.
2
The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum.II型致死性发育不良突变阻碍成纤维细胞生长因子受体3(FGFR3)的完全成熟,FGFR3可从内质网激活信号转导和转录激活因子1(STAT1)。
J Biol Chem. 2003 May 9;278(19):17344-9. doi: 10.1074/jbc.M212710200. Epub 2003 Mar 6.
3
Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells.在PC12细胞中,持续性ERK1/2激活而非STAT1或STAT3激活是致死性发育异常表型所必需的。
Hum Mol Genet. 2005 Jun 1;14(11):1529-38. doi: 10.1093/hmg/ddi161. Epub 2005 Apr 20.
4
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4.FGFR1、FGFR3和FGFR4衍生物介导的转化与Stat激活
Oncogene. 2000 Jul 6;19(29):3309-20. doi: 10.1038/sj.onc.1203650.
5
Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLCgamma-activated STAT1.突变型FGFR3的持续磷酸化是遗传性侏儒症的关键特征,并通过PLCγ激活的STAT1诱导ATDC5软骨生成细胞系发生凋亡。
Bone. 2007 Aug;41(2):273-81. doi: 10.1016/j.bone.2006.11.030. Epub 2007 Feb 9.
6
Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.成纤维细胞生长因子受体3半胱氨酸替代突变体的差异激活由半胱氨酸定位决定。
J Bone Miner Res. 2002 May;17(5):860-8. doi: 10.1359/jbmr.2002.17.5.860.
7
Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.导致软骨发育不全和致死性发育异常的突变对成纤维细胞生长因子受体3的分级激活。
Nat Genet. 1996 Jun;13(2):233-7. doi: 10.1038/ng0696-233.
8
Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias.FGFR3、Stat1、Stat5和p21Cip1的过表达与FGFR3相关软骨发育不全的表型严重程度和软骨细胞分化缺陷相关。
Bone. 2004 Jan;34(1):26-36. doi: 10.1016/j.bone.2003.09.002.
9
Expression of fibroblast growth factor receptor-3 (FGFR3), signal transducer and activator of transcription-1, and cyclin-dependent kinase inhibitor p21 during endochondral ossification: differential role of FGFR3 in skeletal development and fracture repair.成纤维细胞生长因子受体-3(FGFR3)、信号转导和转录激活因子-1以及细胞周期蛋白依赖性激酶抑制剂p21在软骨内成骨过程中的表达:FGFR3在骨骼发育和骨折修复中的不同作用
Endocrinology. 2003 Oct;144(10):4659-68. doi: 10.1210/en.2003-0158. Epub 2003 Jul 3.
10
FGFR3 isoforms have distinct functions in the regulation of growth and cell morphology.成纤维细胞生长因子受体3(FGFR3)亚型在生长调节和细胞形态方面具有不同的功能。
Biochem Biophys Res Commun. 2002 Jan 11;290(1):113-20. doi: 10.1006/bbrc.2001.6190.

引用本文的文献

1
Identification of a novel, pathogenic variant in a patient with Menke-Hennekam syndrome: a Case Report.一名患有门克斯-亨内坎综合征患者的新型致病变异体鉴定:病例报告
Front Genet. 2025 Aug 11;16:1585453. doi: 10.3389/fgene.2025.1585453. eCollection 2025.
2
Advances in the mechanism and therapies of achondroplasia.软骨发育不全的发病机制与治疗进展
Genes Dis. 2024 Sep 24;12(4):101436. doi: 10.1016/j.gendis.2024.101436. eCollection 2025 Jul.
3
Role of signaling pathways in age-related orthopedic diseases: focus on the fibroblast growth factor family.
信号通路在与年龄相关的骨科疾病中的作用:以成纤维细胞生长因子家族为重点。
Mil Med Res. 2024 Jun 21;11(1):40. doi: 10.1186/s40779-024-00544-5.
4
Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.成纤维细胞生长因子5(FGF5)作为前列腺癌潜在治疗靶点的作用
Am J Clin Exp Urol. 2023 Dec 15;11(6):452-466. eCollection 2023.
5
Fibroblast Growth Factors and Cellular Communication Network Factors: Intimate Interplay by the Founding Members in Cartilage.成纤维细胞生长因子和细胞通讯网络因子:软骨中成纤维细胞生长因子家族成员的密切相互作用。
Int J Mol Sci. 2022 Aug 2;23(15):8592. doi: 10.3390/ijms23158592.
6
Cranial Base Synchondrosis: Chondrocytes at the Hub.颅底骺软骨:软骨细胞的中心。
Int J Mol Sci. 2022 Jul 15;23(14):7817. doi: 10.3390/ijms23147817.
7
Anti-fibrotic effects of pharmacologic FGF-2: a review of recent literature.药物 FGF-2 的抗纤维化作用:近期文献综述。
J Mol Med (Berl). 2022 Jun;100(6):847-860. doi: 10.1007/s00109-022-02194-3. Epub 2022 Apr 28.
8
Biological Significance and Targeting of the FGFR Axis in Cancer.成纤维细胞生长因子受体(FGFR)轴在癌症中的生物学意义及靶向作用
Cancers (Basel). 2021 Nov 13;13(22):5681. doi: 10.3390/cancers13225681.
9
The hypertrophic chondrocyte: To be or not to be.肥大软骨细胞:生存还是毁灭。
Histol Histopathol. 2021 Oct;36(10):1021-1036. doi: 10.14670/HH-18-355. Epub 2021 Jun 17.
10
Identification and Tissue-Specific Characterization of Novel SHOX-Regulated Genes in Zebrafish Highlights SOX Family Members Among Other Genes.斑马鱼中新型 SHOX 调控基因的鉴定及组织特异性表征凸显了 SOX 家族成员及其他基因。
Front Genet. 2021 May 27;12:688808. doi: 10.3389/fgene.2021.688808. eCollection 2021.